Engineered Fn3 protein has targeted therapeutic effect on mesothelin‐expressing cancer cells and increases tumor cell sensitivity to chemotherapy-Reference-Cited by-同舟云学术

Engineered Fn3 protein has targeted therapeutic effect on mesothelin‐expressing cancer cells and increases tumor cell sensitivity to chemotherapy

Published:2019-11-12 Issue:2 Volume:117 Page:330-341
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnology and Bioengineering

Author:

Sirois Allison R.¹²,Deny Daniela A.³,Li Yanxuan²,Fall Yacine D.³,Moore Sarah J.¹²⁴^ORCID

Affiliation:

1. Molecular and Cellular Biology ProgramUniversity of Massachusetts AmherstAmherst Massachusetts

2. Picker Engineering ProgramSmith CollegeNorthampton Massachusetts

3. Biochemistry ProgramSmith CollegeNorthampton Massachusetts

4. Department of Biological SciencesSmith CollegeNorthampton Massachusetts

Funder

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27204

Reference66 articles.

1. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

2. Mesothelin Is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE);Argani P.;Clinical Cancer Research,2001

3. Combination therapy in combating cancer;Bayat Mokhtari R.;Oncotarget,2017

4. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers

5. Mesothelin Is Not Required for Normal Mouse Development or Reproduction

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins;Frontiers in Bioengineering and Biotechnology;2024-03-20

2. Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components;The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2022-11-03

3. Protein scaffolds: antibody alternatives for cancer diagnosis and therapy;RSC Chemical Biology;2022

4. FN3 Domain Displaying Double Epitopes: A Cost-Effective Strategy for Producing Substitute Antigens;Frontiers in Molecular Biosciences;2021-11-04

5. Association of genetic variants in the 3′‐untranslated region of the mesothelin ( MSLN ) gene with ovarian carcinoma;Journal of Biochemical and Molecular Toxicology;2020-09-30